Search details
1.
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia.
iScience
; 25(7): 104613, 2022 Jul 15.
Article
in English
| MEDLINE | ID: mdl-35800767
Results
1 -
1
de 1
1
Next >
>>